Detalhe da pesquisa
1.
B Cells of Early-life Origin Defined by RAG2-based Lymphoid Cell Tracking under Native Hematopoietic Conditions.
J Immunol
; 2024 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38874543
2.
CD98 regulates the phosphorylation of HER2 and a bispecific anti-HER2/CD98 antibody inhibits the growth signal of human breast cancer cells.
Genes Cells
; 28(5): 374-382, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36811310
3.
MEK inhibition suppresses metastatic progression of KRAS-mutated gastric cancer.
Cancer Sci
; 113(3): 916-925, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34931404
4.
Antitumor effects of novel mAbs against cationic amino acid transporter 1 (CAT1) on human CRC with amplified CAT1 gene.
Cancer Sci
; 112(2): 563-574, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33211385
5.
Vasodilator oxyfedrine inhibits aldehyde metabolism and thereby sensitizes cancer cells to xCT-targeted therapy.
Cancer Sci
; 111(1): 127-136, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31692172
6.
Endothelial-Mesenchymal Transition Drives Expression of CD44 Variant and xCT in Pulmonary Hypertension.
Am J Respir Cell Mol Biol
; 61(3): 367-379, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30897333
7.
Sulfasalazine could modulate the CD44v9-xCT system and enhance cisplatin-induced cytotoxic effects in metastatic bladder cancer.
Cancer Sci
; 110(4): 1431-1441, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30719824
8.
Glutaminolysis-related genes determine sensitivity to xCT-targeted therapy in head and neck squamous cell carcinoma.
Cancer Sci
; 110(11): 3453-3463, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31444923
9.
Anti-tumor effects of mAb against L-type amino acid transporter 1 (LAT1) bound to human and monkey LAT1 with dual avidity modes.
Cancer Sci
; 110(2): 674-685, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30548114
10.
Epidermal growth factor receptor promotes glioma progression by regulating xCT and GluN2B-containing N-methyl-d-aspartate-sensitive glutamate receptor signaling.
Cancer Sci
; 109(12): 3874-3882, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30298963
11.
Switching subtype-selectivity: Fragment replacement strategy affords novel class of peroxisome proliferator-activated receptor α/δ (PPARα/δ) dual agonists.
Bioorg Med Chem Lett
; 27(14): 3131-3134, 2017 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28539218
12.
CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment.
Cancer Sci
; 107(7): 991-1000, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27176078
13.
Development of an ErbB4 monoclonal antibody that blocks neuregulin-1-induced ErbB4 activation in cancer cells.
Biochem Biophys Res Commun
; 470(1): 239-244, 2016 Jan 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-26780728
14.
Discovery of N-(1-(3-(4-phenoxyphenyl)-1,2,4-oxadiazol-5-yl)ethyl)acetamides as novel acetyl-CoA carboxylase 2 (ACC2) inhibitors with peroxisome proliferator-activated receptor α/δ (PPARα/δ) dual agonistic activity.
Bioorg Med Chem
; 24(21): 5258-5269, 2016 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27591006
15.
Structure-activity relationship studies of non-carboxylic acid peroxisome proliferator-activated receptor α/δ (PPARα/δ) dual agonists.
Bioorg Med Chem
; 24(21): 5455-5461, 2016 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27622746
16.
The orphan G protein-coupled receptor 141 expressed in myeloid cells functions as an inflammation suppressor.
J Leukoc Biol
; 115(5): 935-945, 2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38226682
17.
HER4 and EGFR Activate Cell Signaling in NRG1 Fusion-Driven Cancers: Implications for HER2-HER3-specific Versus Pan-HER Targeting Strategies.
J Thorac Oncol
; 19(1): 106-118, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37678511
18.
Dual-targeting therapy against HER3/MET in human colorectal cancers.
Cancer Med
; 12(8): 9684-9696, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36751113
19.
NIH3T3 cells overexpressing CD98 heavy chain resist early G1 arrest and apoptosis induced by serum starvation.
Cancer Sci
; 103(8): 1460-6, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22497681
20.
Oncogenicity of L-type amino-acid transporter 1 (LAT1) revealed by targeted gene disruption in chicken DT40 cells: LAT1 is a promising molecular target for human cancer therapy.
Biochem Biophys Res Commun
; 406(4): 649-55, 2011 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-21371427